US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

63.63

+0.07440.12%

Post-market: 63.50-0.1290-0.20%16:10 EDT

Volume:9K

Turnover:589.16K

Market Cap:274.88M

PE:20.81

High:63.63

Open:63.27

Low:62.99

Close:63.55

52wk High:64.10

52wk Low:39.10

Shares:4.32M

Float Shares:4.32M

Volume Ratio:0.27

T/O Rate:0.22%

Dividend:1.53

Dividend Rate:2.40%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

Truist Raises Revolution Medicines PT on Lung Cancer Pipeline Potential

Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand

BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development

Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan

3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axsome Therapeutics (AXSM)

Axsome Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Sector Update: Healthcare Stocks Edge Higher Premarket Monday

MT Newswires Live

Axsome Therapeutics Shares Reverse Course Premarket; Last up 2.2%

THOMSON REUTERS

Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook

Analysts’ Top Healthcare Picks: Xencor (XNCR), Revolution Medicines (RVMD)

CervoMed Q2 Net Loss Lower than Estimates as Costs Drop

Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth

Axsome Therapeutics Shares Down 8.4% Premarket After Q2 Revenue Miss

THOMSON REUTERS

Axsome Q2 FY26 Net Loss Widens to $51.3 Million; Net Product Revenue Climbs 46% to $218.4 Million Year over Year

Axsome Therapeutics Q2 Net Income USD -51.314 Million

Axsome Therapeutics Q2 EPS USD -0.99

THOMSON REUTERS

Axsome Therapeutics Q2 Operating Expenses USD 268.021 Million

THOMSON REUTERS

Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PTH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":63.629,"timestamp":1787774400000,"preClose":63.5546,"halted":0,"volume":9295,"hourTrading":{"tag":"盘后","latestPrice":63.5,"preClose":63.629,"latestTime":"16:10 EDT","volume":19,"amount":1212.3165,"timestamp":1787775005417,"change":-0.129,"changeRate":-0.002027,"amplitude":0},"delay":0,"changeRate":0.0011706469712656068,"floatShares":4320000,"shares":4320000,"eps":3.057033,"marketStatus":"Closed","change":0.0744,"latestTime":"08-26 16:00:00 EDT","open":63.27,"high":63.629,"low":62.985,"amount":589164,"amplitude":0.010133,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787817600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":63.5546,"sharesOutstanding":2480000,"nav":63.56092,"aum":280939266.4,"dividendRate":0.023972,"bidAskSpread":0.002223,"preHourTrading":{"tag":"盘前","latestPrice":63.5546,"preClose":63.5546,"latestTime":"07:01 EDT","volume":1,"amount":63.5546,"timestamp":1787742068433,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":63.5,"preClose":63.629,"latestTime":"16:10 EDT","volume":19,"amount":1212.3165,"timestamp":1787775005417,"change":-0.129,"changeRate":-0.002027,"amplitude":0},"volumeRatio":0.26737,"impliedVol":0.0861,"impliedVolPercentile":0.2629},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4320000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.26737,"shares":4320000,"dividePrice":1.5253,"high":63.629,"amplitude":0.010133,"preClose":63.5546,"low":62.985,"week52Low":39.1,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":63.629,"eps":3.057033,"divideRate":0.023972,"volume":9295,"delay":0,"ttmEps":3.057033,"open":63.27,"prevYearClose":49.701,"prevWeekClose":62.9761,"prevMonthClose":58.0963,"prevQuarterClose":59.76,"fiveDayClose":64.0724,"twentyDayClose":57.08,"sixtyDayClose":50.8485},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658130309","title":"U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2658130309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658130309?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:21","pubTimestamp":1786454464,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal HealthAugust 11 (Reuters)-Wall Street's main indexes were poised to open higher on Tuesday as investors welcomed a report suggesting the United ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL6N4480DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","BK4141","LU2008162690.USD","LU0511384066.AUD","BYND","IDNA","LU0441851309.USD","BK4116","BK4547","URAN","BK4564","LU0162691827.USD","IE0009354923.USD","LU0057025933.USD","BK4225","JXI","LU1861220207.SGD","LU1880398471.USD","IE0002141913.USD","LU0640476718.USD","BK4077","LU0889565916.HKD","LU2065169927.USD","NERD","LU0211327993.USD","IE0001KFT4U8.USD","BK4085","LU0737861269.HKD","BK4535","LU0251143029.SGD","LU2152927971.USD","CRWV","LU1323610961.USD","LU1267930490.SGD","RHP","HERO","LU2362540622.SGD","RKLZ","NUKX","SG9999001135.SGD","BK4613","CWII","WSPC","LU2065171402.SGD","NETG","HIYY","LU1861215975.USD","FUTY","LU0979878070.USD","NETX","SG9999002414.USD","SG9999006266.SGD","LU0516423174.USD","BK4220","LU1244550577.SGD","JAN","IE0009355771.USD","LU1770036033.HKD","LU0345775950.USD","HMYY","FSPC","LU0589944569.HKD","AHR","BK4196","GLAM","ONON","WBTN","BK4566","STTK","XLC","HEAL","HIMS","SG9999002679.SGD","LU1621767810.EUR","LU2238330802.EUR","LU2543165471.USD","LU0516422366.SGD","LU1048588211.SGD","SG9999005177.SGD","LU1242518857.USD","LU2065171311.SGD","BK4081","LU0109394709.USD","BK4548","IE0031814969.USD","SG9999002604.SGD","DIPR","LU0823038988.USD","NURE","LU0499858438.USD","XITK","LU1244550221.USD","LU0210637038.USD","IE00B4R5TH58.HKD","BK4187","SG9999013478.USD","LU1430594728.SGD","IE00BD6J9T35.USD","SG9999004360.SGD","LU2362541513.USD","BK4094","CANC","LU1267930227.SGD","BK4023","CRWU","BK4551","IE00BJJMRZ35.SGD","FXG","LU2065170008.USD","UFO","BK4202","BK4007","LU0211328371.USD","LU1242518931.SGD","LU0175139822.USD","LU0264606111.USD","LU1861558580.USD","BK4585","VG","XLU","WTRE","LU2125910849.SGD","LU1861559042.SGD","BK4181","RVMD","SFD","UPW","DUK","LU1571399168.USD","SGXZ58947870.SGD","MEDI","IE00BFTCPJ56.SGD","XDAT","LU0823039010.USD","HIMZ","LU0048573645.USD","LU1880398554.USD","LU2125910500.SGD","LU2384288077.EUR","BK4505","LEGN","BK4213","FDNI","BK4139","GAP","IE00B29SXK94.USD","LU1585245621.USD","CRWG","TTWO","LU1621768206.USD","ASTS","PTH","ASTN","LU2360107671.USD","LU0472753341.HKD","IDU","WARP","ACIU","LU0128525689.USD","BK4175","LU0289739343.SGD","IE00B29SXL02.USD","BK4526","CLOU","RKLX","HIMY","LU1621767737.EUR","IE0034224299.USD","IE00BJT1NW94.SGD","LU0719512351.SGD","LU0289961442.SGD","BK4212","LU2286300806.USD","ASTX","SG9999001440.SGD","LU0320765992.SGD","LU0069063385.USD","LU0006061336.USD","SG9999013486.USD","SG9999002950.SGD","LU1983299246.USD","LU0274383776.USD","BK4554","LU1267930813.SGD","RKLB","SG9999002620.SGD","SIMO","LU1861220033.SGD","BBH","LU0889566641.SGD","LU2463526074.USD","MEMS","NET","THNR","BK4503","LU0572940350.SGD","LU0072461881.USD","BK4606","LU1804176565.USD","LU2362541273.HKD","IE00B2B36J28.USD","LU2089985449.USD","LU0516422440.USD","TRUU","BNGE","MARS","BK4120","BK4524","LU0572939691.SGD","BK4089","BSP","SG9999013460.SGD","LU0081259029.USD","LU0261945553.USD","BK4146","LU0792757196.USD","LU0061475181.USD","LU0072462343.USD","LU1244550494.USD","LU2177674079.SGD","BK4218","SG9999002406.SGD","LU2045819591.USD","LU0516423091.SGD","ORBX","UAA","CORD","LU0310799852.SGD","CAH","BK4615","LU2290526834.HKD","LU0310800965.SGD","LU0345776255.USD","LU0499858602.USD","SE","LU0289960550.SGD","VPU","LU1621768115.EUR","BK4607","LU0052756011.USD","AIS","LU0532188223.SGD","BK4560","ESPO","LU0516422952.EUR","LU2265009873.SGD","LU0082616367.USD","LU1280957306.USD","CWVX","BK4581","SG9999014484.SGD","LTL","IE000M9KFDE8.USD","LU1861217088.USD","LU2360107168.USD","SG9999014492.USD","LU1839390173.USD","RSPC","FPWR","BK4588","LU0348788117.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658528997","title":"Truist Raises Revolution Medicines PT on Lung Cancer Pipeline Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2658528997","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658528997?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:41","pubTimestamp":1786448509,"startTime":"0","endTime":"0","summary":"BUZZ-Truist raises Revolution Medicines PT on lung cancer pipeline potential** Brokerage Truist Securities raises price target for Revolution MedicinesRVMD.Oto $231 from $210** Maintains \"buy\" rating** Says recent advancement of elironrasib and zoldonrasib into late-stage studies in first-line non-small cell lung cancer  strengthens RVMD's position in RAS-targeted cancers** Sees both programs expanding RVMD's addressable market in lung cancer and supporting a more diversified RAS franchise**The new price target represents a 11.6% upside to the stock's last close** Brokerage continues to expect potential approval ofdaraxonrasibin previously treated pancreatic cancer in Q3 2026** \"While pricing remains an open question, mgmt expressed confidence that organizational, market access, patient-support and distribution capabilities will not be limiting factors\" - Truist says** As of last close, stock has more than doubled YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N4480SP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","IE0002141913.USD","IE00B2B36J28.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","BK4139","IDNA","IE0009355771.USD","PTH","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","CANC","IE0009354923.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658925009","title":"Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2658925009","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658925009?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:10","pubTimestamp":1786446639,"startTime":"0","endTime":"0","summary":"Fennec Pharmaceuticals Q2 sales rise on PEDMARK demandOverviewUS specialty pharma's Q2 net product sales rose 78% yr/yr, driven by PEDMARK demandNon-GAAP adjusted EBITDA for Q2 turned positive from a ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","FENC","HRTX","PTH","BK4007","AXSM","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123475942","title":"BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1123475942","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123475942?lang=en_us&edition=fundamental","pubTime":"2026-08-11 09:46","pubTimestamp":1786412777,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160) saw its shares surge more than 4% during early trading hours, before settling at a 2.72% gain to 219 Hong Kong dollars, with a trading volume of 297 million Hong Kong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","KCAI","IE00BJT1NW94.SGD","BK1500","BK4526","IE0009354923.USD","06160","IE00B4R5TH58.HKD","LU0828237510.HKD","BBH","LU1770034418.SGD","IE0002141913.USD","LU0109394709.USD","IE00B2B36J28.USD","LU1303224171.USD","688235","BK1161","LU1969619763.USD","IDNA","IE00BFTCPJ56.SGD","LU0228659784.USD","IE00BJJMRZ35.SGD","LU1719994722.HKD","LU2328871848.SGD","BK4139","CANC","IE0009355771.USD","LU0320765992.SGD","LU0307460666.USD","LU0588546209.SGD","LU1251922891.USD","ONC","PTH","KURE","BK1588","LU0889565916.HKD","BK4588","BK4585","BK0239","BK1583","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658599689","title":"Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2658599689","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658599689?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:13","pubTimestamp":1786392812,"startTime":"0","endTime":"0","summary":"Guardant Health grants 46,044 RSUs to 149 new employees under inducement planGuardant Health set inducement RSU grants covering 46,044 common shares for 149 new non-executive hires, with an Aug. 3, 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL208d3j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","PTH","FFOX","GNOM","LFSC","BK4585","BK4535","LU0889565916.HKD","HELX","BK4551","LU0320765992.SGD","GDOC","LU0109394709.USD","GH","BK4588","BK4196","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658295379","title":"3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658295379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658295379?lang=en_us&edition=fundamental","pubTime":"2026-08-11 01:44","pubTimestamp":1786383867,"startTime":"0","endTime":"0","summary":"We are diving into three healthcare stocks which all have a Strong Buy consensus and a 10 out of 10 TipRanks Smart Score. The Smart Score is a prop...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-perfect-ten-healthcare-stocks-that-analysts-rate-as-a-strong-buy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-perfect-ten-healthcare-stocks-that-analysts-rate-as-a-strong-buy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","XBI","BGIG","BK4581","TCAF","XLVX","BK4137","CGCV","NOBL","XLV","IXJ","LU0128526141.USD","OEFA","BK4585","LU0029874061.USD","DVXV","BK4588","VHT","PTH","JHMH","BK4550","HCSG","CURE","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658584679","title":"Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658584679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658584679?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:50","pubTimestamp":1786380608,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axso...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-heron-therapeutics-hrtx-aquestive-therapeutics-aqst-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-heron-therapeutics-hrtx-aquestive-therapeutics-aqst-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","HRTX","LABU","LU0029874061.USD","HCSG","LU0128526141.USD","AXSM","BK4139","LU2324357040.USD","BK4581","BK4585","BK4137","XBI","BK4505","PTH","BK4588","AQST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658393127","title":"Axsome Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658393127","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658393127?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:30","pubTimestamp":1786368646,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings SummaryAxsome Therapeutics, Inc.AXSM.OQreported a quarterly adjusted loss of 99 cents per share for the quarter ended","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N447157:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4505","AXSM","BK4585","LU2324357040.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658155931","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2658155931","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658155931?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:18","pubTimestamp":1786367886,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) slightly advancing and the iShares Biotechnology ETF (IBB) up 0.5%.Sionna Therapeu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","ABCL","BK4007","BK4139","BK4535","LABU","AXSM","BK4121","BK4137","BK4505","SION","BK4581","XLV","IBB","PTH","HCSG","LU0029874061.USD","BK4585","XBI","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658293618","title":"Axsome Therapeutics Shares Reverse Course Premarket; Last up 2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658293618","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658293618?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:20","pubTimestamp":1786364445,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","PTH","BK4585","BK4007","LU2324357040.USD","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658593507","title":"Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658593507","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658593507?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:08","pubTimestamp":1786363720,"startTime":"0","endTime":"0","summary":"Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlookOverviewUS biotechnology firm's Q2 net revenue rose 1.3% yr/yr to $37.7 mlnCompany withdrew full-year 2026 guidance citi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470CA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","BIAF","BK4139","AXSM","HRTX","LU2324357040.USD","BK4007","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658354779","title":"Analysts’ Top Healthcare Picks: Xencor (XNCR), Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658354779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658354779?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:50","pubTimestamp":1786362616,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Xencor (XNCR), Revolution Medicines (RVMD) and Roiva...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-xencor-xncr-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-xencor-xncr-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","IE00B4R5TH58.HKD","IE0002141913.USD","BK4588","IE0009354923.USD","IE00BJT1NW94.SGD","LU0109394709.USD","BK4139","LU0029874061.USD","XLV","LU0889565916.HKD","XNCR","BK4137","PTH","IE00BJJMRZ35.SGD","LU0320765992.SGD","CANC","BK4581","IE00B2B36J28.USD","LU0128526141.USD","BK4585","RVMD","IE0009355771.USD","XBI","BBH","LABU","HCSG","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658443933","title":"CervoMed Q2 Net Loss Lower than Estimates as Costs Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2658443933","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658443933?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:38","pubTimestamp":1786361915,"startTime":"0","endTime":"0","summary":"CervoMed Q2 net loss lower than estimates as costs dropOverviewUS biotech developer's Q2 net loss was lower than analyst expectationsCompany completed $20.5 mln equity financings, extending cash runwa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470AO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM","BK4139","LU2324357040.USD","PTH","CRVO","BK4505","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938415","title":"Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938415","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938415?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:10","pubTimestamp":1786360249,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics Q2 revenue rises on AUVELITY growthOverviewUS biopharmaceutical firm's Q2 revenue grew 46% yr/yr but missed analyst expectationsNet loss for Q2 widened slightly compared to last ye","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N44709M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4539","ANIP","BK4139","LU0566484027.USD","LU1559883803.SGD","BK4082","PTH","BK4007","GYRE","AXSM","BK4585","LU2324357040.USD","TMCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658893819","title":"Axsome Therapeutics Shares Down 8.4% Premarket After Q2 Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658893819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658893819?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:08","pubTimestamp":1786360128,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470MO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","BK4007","LU2324357040.USD","BK4585","BK4505","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658381179","title":"Axsome Q2 FY26 Net Loss Widens to $51.3 Million; Net Product Revenue Climbs 46% to $218.4 Million Year over Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2658381179","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658381179?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:08","pubTimestamp":1786360116,"startTime":"0","endTime":"0","summary":"Axsome Q2 FY26 net loss widens to $51.3 million; net product revenue climbs 46% to $218.4 million year over yearAxsome posted 2Q 2026 net product revenue of $218.4 million, up 46% year over year.Net l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL4b4sNn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","LU2324357040.USD","BK4585","BK4505","BK4007","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658383679","title":"Axsome Therapeutics Q2 Net Income USD -51.314 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658383679","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658383679?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:01","pubTimestamp":1786359662,"startTime":"0","endTime":"0","summary":"BRIEF-Axsome Therapeutics Q2 Net Income USD -51.314 MillionAug 10 (Reuters) - Axsome Therapeutics Q2 pretax profit USD -51.186 million.Q2 operating income USD -49.646 millionQ2 operating expenses USD 268.021 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX24BRB4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","LU2324357040.USD","PTH","BK4007","BK4585","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938554","title":"Axsome Therapeutics Q2 EPS USD -0.99","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938554","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938554?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX24BRB4:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AXSM","BK4007","LU2324357040.USD","BK4585","PTH","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658777980","title":"Axsome Therapeutics Q2 Operating Expenses USD 268.021 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658777980","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658777980?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX24BRB4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4505","PTH","LU2324357040.USD","BK4007","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658798005","title":"Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658798005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658798005?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA9MN6XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","LU2324357040.USD","PTH","AXSM","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}